seeking partner for future development BT1702BT1702 / MT1-MMP / Bicycle Radioligand / OncologyMT1-MMP-expressing tumorsIND-enabling / human imagingCompany-sponsored BRC clinical trial planned in 2027 ION286/AZD4063ION286/AZD4063 / TfR1 / TfR1-targeted Bicycle conjugate / CardiomyopathyCardiomyopathyPhase 1Ongoing 5assets BMN 333BMN 333 / C-type natriuretic peptide pathway / Long-acting CNP peptide / Skeletal ConditionsAchondroplasiaPhase 2/3Registration-enabling study enrolling BMN 351BMN 351 / Dystrophin / Oligonucleotide / InnovationDuchenne muscular dystrophyPhase 1/2Clinical data update expected year-end 2026 BMN 401BMN 401 / ENPP1 / Subcutaneous enzyme replacement therapy / Enzyme TherapiesENPP1 deficiencyPhase 3ENERGY 3 met 1 of 2 co-primary endpoints
The half-life sits at approximately 5 days
Why Formulation Design Impacts Digestion When considering if glutathione might cause stomach pain, it is important to look at what else is in the bottle
Feature and Application Health Benefits A lot of clinical studies have shown that GHK-Cu has different roles and benefits in the human body, including: Wound healing
high-dose riboflavin (10 mg kg 1 day 1 ) or flavin esters rapidly restore ATP production and cell viability in vitro ( SLC52A3 knock-down and SLC52A3 / mice recapitulate hearing loss, ataxia and early death, all of which improve with systemic riboflavin supplementation ( SLC52A2 gene replacement normalized FMN/FAD levels, rescued spinal motor neurons and reversed motor deficits when delivered pre-symptomatically, underscoring the feasibility of curative therapy ( Clinically, oral or intravenous riboflavin remains first-line treatment
Think of your skin barrier like a brick wall, with skin cells as the bricks and lipids as the mortar